Study into prophylaxis treatment meets key endpoints
Results showed a clinically meaningful prevention of bleeds in people with severe haemophilia A - News - PharmaTimes
Source: pharmatimes.com
Page 11 - Anders Ullman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Anders Ullman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Anders Ullman Today - Breaking & Trending Today
Sanofi's hemophilia A data set stage for regulatory filings, matchup with Roche
An experimental hemophilia A therapy from Sanofi and partner Sobi has met the goals of a pivotal study, and the pharmaceutical giant is now planning global regulatory submissions for later this year. The drug could compete against a blockbuster hemophilia A treatment marketed by Roche.
Source: medcitynews.com
Swedish Orphan Biovitrum AB: Sobi to present new data at EAHAD 2022
STOCKHOLM, Feb. 2, 2022 /PRNewswire/ -- Sobi will present new data at the 15th European Association of Haemophilia and Allied Disorders (EAHAD) virtual conference from 2-4 February 2022, contributing
Source: finanznachrichten.de
Sobi to present new data at EAHAD 2022
/PRNewswire/ -- Sobi™ will present new data at the 15th European Association of Haemophilia and Allied Disorders (EAHAD) virtual conference from 2-4 February...
Source: prnewswire.com
Sobi to present new data at EAHAD 2022
/PRNewswire/ -- Sobi™ will present new data at the 15th European Association of Haemophilia and Allied Disorders (EAHAD) virtual conference from 2-4 February...
Source: prnewswire.com